Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI

BACKGROUND AND OBJECTIVES: De-escalation of dual-antiplatelet therapy through dose reduction of prasugrel improved net adverse clinical events (NACEs) after acute coronary syndrome (ACS), mainly through the reduction of bleeding without an increase in ischemic outcomes. Whether the benefits of de-es...

Descripción completa

Detalles Bibliográficos
Autores principales: Ki, You-Jeong, Lee, Bong Ki, Park, Kyung Woo, Bae, Jang-Whan, Hwang, Doyeon, Kang, Jeehoon, Han, Jung-Kyu, Yang, Han-Mo, Kang, Hyun-Jae, Koo, Bon-Kwon, Kim, Dong-Bin, Chae, In-Ho, Moon, Keon-Woong, Park, Hyun Woong, Won, Ki-Bum, Jeon, Dong Woon, Han, Kyoo-Rok, Choi, Si Wan, Ryu, Jae Kean, Jeong, Myung Ho, Cha, Kwang Soo, Kim, Hyo-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989793/
https://www.ncbi.nlm.nih.gov/pubmed/35129316
http://dx.doi.org/10.4070/kcj.2021.0293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989793/
https://www.ncbi.nlm.nih.gov/pubmed/35129316
http://dx.doi.org/10.4070/kcj.2021.0293

Ejemplares similares